health
A scientist’s opinion : Interview with Professor Maurice Whelan about animal testing
Animal testing, a scientist’s opinion Interview with Maurice Whelan, head of EURL ECVAM (European Union Reference Laboratory for alternatives to animal testing (EURL ECVAM) at the JRC (Joint Research Centre of the European Commission) in Ispra, Italy. How do you think progress is going on reducing animal use for scientific purposes, and what is the ...
A scientist’s opinion : Interview with Professor PierFranco Conte about animal testing
Animal testing, a scientist’s opinion Interview with Professor PierFranco Conte, Full Professor of Oncology at the University of Padova and Director of the Division of Medical Oncology 2 at the Istituto Oncologico Veneto in Padova. In your opinion, why is animal use for scientific purposes still so common place? Are animal models still essential for ...
A scientist’s opinion : Interview with Dr Jason Johnson about animal testing
Interview with Dr Jason Johnson, British Heart Foundation Senior Research Fellow, Associate Professor of Cardiovascular Pathology, and leads the Laboratory of Cardiovascular Pathology at Bristol Medical School, University of Bristol. As a scientist, in general do you find that the 3Rs concept is something that is routinely thought of when discussing experimental plans, or is ...
A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research
Interview with Aroon Hingorani, Professor of Genetic Epidemiology at University College London about Re-engineering pharmaceutical research. Could you speculate what you think are the biggest causes of drug failure? Aroon Hingorani: It is well recognised that the number one cause for drug failure is a lack of efficacy of the drug in the intended indication, ...
A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research
Interview with Dr Denis Lacombe, Director General of the European Organisation for Research and Treatment of Cancer (EORTC) about Re-engineering pharmaceutical research. Can you tell me a bit about the European Organisation for Research and Treatment of Cancer (EORTC)? Denis Lacombe: We are a non-governmental, not-for-profit organisation established for 60 years, focusing on survival and ...
A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research
Interview with Dr Síle Lane, head of international campaigns and policy at Sense About Science, about Re-engineering pharmaceutical research. Undisclosed clinical trial results are unfortunately common - how does this impact progression in research and treatment? Síle Lane: When results from clinical trials aren’t published it means the same research can get repeated unnecessarily. This ...
EU Project : PhilHumans
PhilHumans : The goal of the PhilHumans (Personal Health Interfaces Leveraging Human-MAchine Natural interactionS) project is to train a next generation of young researchers in innovative Artificial Intelligence (AI) and establish user interaction with their personal health devices in an advanced and intuitive way. PhilHumans will investigate cutting-edge AI methods for human-machine interaction in the ...
EU Project : CLARIFY
CLARIFY : There were 17 million new cases of cancer diagnosed worldwide in 2018. Survival rates of cancer patients were rather poor until recent decades, when diagnostic techniques have been improved and novel therapeutic options have been developed. It is estimated that more than 50% of adult patients diagnosed with cancer live at least 5 ...